Key result
Type 1 and type 2 diabetes linked to ~5-fold higher cardiovascular mortality.
Patients affected by diabetes show anincreased risk of cardiovascular dis-ease (CVD) and mortality that re-duces their life expectancy by 5–15 years (depending on the age at diagnosis). An 18-year follow-up study from Finland demonstrated a similar impact of type 1 and type 2 diabetes on cardiovascular mortality, with an increased risk of 5.2 and4.9 times for type 1 and type 2 diabetes, respectively (1). In type 1 diabetes, follow-up results from a large randomized clini-cal trial suggest that the improvement of metabolic control, obtained through in-tensive insulin treatment, can prevent CVD in the long term. On the other hand, despite some encouraging results
No takes yet. Share an insight, caveat, or question.
Mannucci et al. (2013) conducted a review in Diabetes. Intensive insulin treatment (glucose control) was evaluated on Cardiovascular disease and mortality. Type 1 and type 2 diabetes increase the risk of cardiovascular mortality by 5.2 and 4.9 times, respectively, while intensive insulin treatment may prevent long-term CVD in type 1 diabetes.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: